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The expression of mRNA for elafin/SKALP, an inhibitor of 
leukocyte elastase and proteinase 3, in human normal and 
psoriatic epidermis was examined by in situ hybridization. In 
normal epidermis, elafin/SKALP mRNA was detected in the 
granular layer, but not in the spinous or basal layers. In fully 
developed psoriatic lesions, elafin/SKALP mRNA was 
found in the suprabasallayers of the ridges, and in the upper 
two thirds of the stratum malpighii at the elongated rete 
ridges. Intense staining was noted near the subcorneal mi-
croabscess in psoriasis vulgaris and under the subcorneal pus-
tule in localized pustular psoriasis. In the marginal psoriatic 
H uman leukocyte elastase (HLE) is a serine proteinase contained in azurophilic granules of polymorpho-nuclear leukocytes (PMNs) [1,2]. At the site of inflammation, the enzyme is released with other proteinases, proteinase 3, cathepsin G, and colla-
genase, and causes severe tissue injury [1-3]. The degradation prod-
ucts of various matrix components act as chemoattractants and fur-
ther recruit a greater number ofPMNs [4]. The HLE activity is, like 
other proteinases, regulated by endogenous specific inhibitors [1,5]. 
Recently, a novel inhibitor for HLE, named elafin (elastase specific 
inhibitor) [6], SKALP (skin-derived antileukoproteinase) [7,8], and 
ESI (elastase-specific inhibitor) [9], has been found independently, 
from psoriatic epidermis, psoriatic scales, and sputum of patients 
with chronic bronchitis, respectively. Elafin/SKALP, also has po-
tent inhibitory activity against proteinase 3, but not against cathep-
sin G [10]. The eDNA and genomic DNA for elafin/SKALP have 
been cloned and the deduced amino acid sequence indicated a 9.9-
kDa mature protein with a unique structure of four repeats of puta-
tive transglutaminase substrate motifs as well as a proteinase inhibi-
tor domain [11,12]. 
PMNs are the predominant cells infiltrating in psoriatic microab-
scesses and spongiform pustules. In the lesional skin of psoriasis, the 
activity ofHLE is increased and is a sensitive marker for infiltration 
of neutrophils into skin [13,14]. In addition, a large amount of 
elafin/SKALP activity is detected in the psoriatic lesional epidermis 
as well as cultured keratinocytes [7,8], and elafin/SKALP is local-
ized in the suprabasal layers of lesional psoriatic epidermis [15]. 
Hence, the induction of elafin/SKALP gene expression by HLE is 
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epidermis, elafin/SKALP mRNA was expressed from the 
middle or upper spinous layer to the subcorneallayer, and the 
cells expressing elafin/SKALP mRNA increased especially 
under the parakeratotic corneal layer intermingled with pyk-
notic nuclei of neutrophils. These findings suggest that the 
induction of elafin/SKALP gene expression is related closely 
to the infiltration of neutrophils into the epidermis in psoria-
sis and plays an important role in protecting the skin compo-
nents against the tissue damage caused by the infiltrated leu-
kocytes. Key words: proteinase inhibitor/leukocyte elastase/in situ 
hybridization.] Invest DermatoI103:88 - 91, 1994 
suggested to playa crucial role in the pathophysiology of psoriatic 
lesions. 
In this study, we examined the localization of elafin/SKALP 
mRNA in normal and psoriatic epidermis by ill situ hybridization. 
We show the expression of the gene in normal epidermis and its 
dysregulation in psoriatic lesions. 
MATERIALS AND METHODS 
Materials Normal skin specimens were obtained from patients undergo-
ing plastic surgery. Biopsies were taken from typical plaques of patients 
suffering from psoriasis vulgaris (n = 5), from non-Iesional skin of psoriatic 
patients, from the palmar lesion oflocalized pustular psoriasis, and from the 
lesional skin of patients suffering from atopic dermatitis. They had not 
received any treatment for at least 2 weeks prior to sampling. Half of the 
specimen was snap frozen in OCT compound (Miles Laboratories, U .S.A.) 
using liquid nitrogen, and the other half was fixed in formalin and paraffin 
embedded for routine hematoxylin-eosin staining. Frozen sections (5 - 6 J.l1ll 
thick) were made to adhere to glass slides coated with Vectabond (Vector 
Laboratories Inc., U.S.A.) and were rapidly air dried. The sections were fixed 
in phosphate-buffered saline (PBS) containing 4% (w Iv) paraformaldehyde 
for 15 min at room temperature, air-dried, and stored at -70'C until use. 
Construction of Plasm ids and Synthesis of RNA Probes The 0.3-kb 
second exon of the human elafin/SKALP gene (nucleotides; 1184 - 1457) 
[12] was inserted into pDluescript II (Stratagene) and pGEM3Z (Promega 
Biotec) to construct pBSheg1.4r1 and PGEM-heg, respectively. The 
pBSheg1.4r1 plasmid or pGEM-heg plasmid was linearized with BcoRI to 
synthesize the antisense cRNAs or the control sense cRNAs for elafinJ 
SKALP mRNA by T3 or SP6 RNA polymerase, respectively, using a DIG 
RNA Labeling Kit (Boehringer Mannheim) as described p(eviously [16]. 
The full-length transcription of the probes was confirmed by Northern 
hybridization. The eRN As were fragmented by limited alkaline hydrolysis 
[17) and used for ill situ hybridization. 
In $itu Hybridization III situ hybridization was performed as described 
previously (16). The sections were rehydrated in PBS containing 0.3% (w Jv) 
Triton X- lOO tor 15 min, then treated with 0.2 N HCI for 20 mjn. After 
proteinase K digestion (1 Ilg/ml), the sections were post-fixed with 4% 
(w/v) paraformaldehyde in PBS for 5 min. Following acetylation for 10 
min, they were soaked in PBS containing 0.1 M glycine and equilibrated in 
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Figure 1. Localization of elafin/SKALP mRNA in normal epidermis. III situ hybridization was perform.ed using the antise.nse (a ,c,d) or the sense (b) 
elafin/SKALP cRNA probes as described undcr Materials alld Methods. a) Normal epidermiS from the face. Stalllll1g was observed III the subcorneallayer. No 
signal was detccted in the basal, spinous and corneal layers. b) A negative control for a. No signal was detected. c) Normal epidermis of the arm. Staining was 
present in the subcorneal monolayer focally. d) N ormal epidermiS from the sole. Two to three subcorneal layers were stamed. Scale bars, 50 Jun. 
50% formamide containing 2 X SSC (1 X SSC: 15 mM NaCl, 15 mM so-
dium citrate) for 1 h. The sections hybridized in a mixture consisting of 20 
mM Tris-HCl (pH 8.0), 2.5 mM ethylenediaminetetraacetic acid (EDTA), 
50% formamide, 0.3 M NaCl, 1 X Denhardt's solution (Sigma), 1 mg/ml 
yeast tRNA (Sigma), 10% PEG6000, and 0.2 ng/)ll probe. After overnight 
incubation at 45 °C, they were washed for 1 h at 45 °C in 50% formamide 
and 2 X SSC, digested with 10 )lg/ml RNase (Sigma) in 0.5 M NaCI and 10 
mM Tris-HCl (pH 8.0) for 30 min at 37"C. Hybridiza tion signals were 
detected using a Nucleic Acid Detection Kit (Boehringer Mannheim). Neg-
ative control sections hybridized with a sense probe were also examined. 
RESULTS 
Figure la, c, alld d shows the normal skin specimens of healthy 
individuals hybridized with elafin/SKALP antisense cRNA probe. 
In the normal epidermis from the face, elafin/SKALP mRNA was 
detected in the sub corneal layer, but not in the spinous or basal 
layers. In the perifollicular epidermis, subcorneal mRNA expres-
sion was increased (Fig la). III the normal epidermis from the arm, 
mRNA positive cells were found ill the subcorneal monolayer fo-
Figure 2. Localization of elafin/SKALP mRNA in non-lesional and lesional skin of psoriasis vulgaris and in lesional skin of localized pustular psoriasis and 
chronic eczema. Sections were hybridized antisense elafin / SKALP cRNA probe (a - c,e-i). a) Non-lesional epidermis of psoriatic patients. Elafin / SKALP 
mRNA was express cd in the subcorncal monolayer focally. b) Transitional zone from uninvolved to involved psoriatic epidermis. The involvcd psoriatic 
epidermis (the right-hand side) expressed more abundant elafin/SKALP mRNA than the uninvolved epidermis (the left-hand side). In the marginal psoriatic 
epidermis, hybridization was seen from the middle or upper spinous to subcorneallayer. c) High m agnification of (b) . Under the parakeratotic corneal layer 
intermingled with nuclear dust ofPMNs, eiafin/SKALP mRNA expressing cells increased markedly. (d) Hematoxylin-eosin staining of the field correspond-
ing to (c). eJ,g) Expression of elafin/SKALP mRNA in a fully developed psoriatic epidermis. Arrolvheads, epidermal-dermal junction. e) All suprabasallayers 
were stained at the ridge. J) Upper fWO thirds of elongated rete ridge were stained. g) Maximal staining was seen near the subcorneal microabscess. h) 
Expression of eiafin/SKALP mRNA in the palmar lesion of a localized pustular psoriasis. Staining was found in the spinous layers undcr the subcorneal pustule. 
i) Localization of elafin/SKALP mRNA in lesional skin of atopic dermatitis. One or three subcorneallayers were stained.j) Hematoxylin-eosin staining of the 
fie ld corresponding to (i). Scale bar, 100 )lm. 
90 NONOMURA ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY 
VOL. 103. NO.1 JULY 1994 
cally (Fig Ie) . In the normal epidermis of the sole, elafin/SKALP 
mRNA was expressed in two to three subcorneallayers (Fig Id), 
which were identified as granular layers by hematoxylin-eosin 
staining. 
We next examined the distribution of elafin/SKALP mRNA in 
psoriatic epidermis. In non-Iesional epidermis of psoriatic patients, 
elafin/SKALP mRNA expression was seen in the subcorneal mono-
layer focally (Fig 2a). Figure 2b shows a transitional zone from 
uninvolved to involved psoriatic epidermis hybridized with the ela-
fin/SKALP antisense cRNA probe. The involved psoriatic epider-
mis expressed m?re abundant ela~n/SKA~P ~RN.A tha~ the unin-
volved epidermis. In the margmal psonatlc epldenms, mRNA 
expression was found from the middle or upper spinous to the 
sub corneal layer. Under the parakeratotic corneal layer intermin-
gled with pyknotic nuclei of PMNs, the cells expressing elafin/ 
SKALP mRNA increased markedly (Fig 2b,e,d). In fully developed 
psoriatic lesions, hybridization was seen in the suprabasallayers of 
the ridges (Fig 2e), and in the. upper ~o thirds of the stratum 
malpighii at the elongated rete ndges (Fig 2f). Near the sub corneal 
microabscess, maximal staining was observed (Fig 2g). Similarly, in 
palmar lesions o~localize.d pustular psoriasis, elafin/SKALP mRNA 
was distributed m the spmous layers under the subcorneal pustules 
(Fig 2h). In chronic dermatitis with acanthosis of the epidermis (Fig 
2j) elafin/SKALP mRNA expression was found in the one to three 
subcorneallayers (Fig 2i) that roughly corresponded to the granular 
layers. Neither the acanthotic spinous layer nor the basal layer was 
stained. 
DISCUSSION 
A recent immunohistochemical study using antiserum against puri-
fied elafin/SKALP has shown that the elastase inhibitor is present in 
many epidermal cel.ls of lesional skin of psoriasis [15]. This I~caliza­
tion is consistent With that of elafin/SKALP mRNA determmed by 
in situ hybridization. In psoriatic lesions, proteolysis of keratino-
cytes has been observed under .parakeratotic scales and .in the area 
surrounding the subcorneal microabscess [18]. Interestl11gly, cells 
expressing elafin/SKALP mR~A are increased with .downward e~­
tension under the parakeratotic corneal layers contammg pyknotic 
nuclei ofPMNs. Moreover, strong signals of the mRNA are found 
around the subcorneal microabscess filled with PMNs. The pattern 
of the mRNA expression is similar to that of localized pustular 
psoriasis. !I~us, the up-regulation ?f elafi~/SKA~P gene expres~ion 
in psoriaSIS IS closely correlated With the I11filtratlon of PMNs mto 
the epidermis. Because the epidermis of chronic eczema shows 
acanthosis without PMN infiltration into the epidermis, elafin/ 
SKALP gene is expressed only in the thickened granular layer de-
spite the presence of acanthosis. A factor, or the proteinases released 
from the infiltrating PMNs, may strongly induce the elafin/ 
SKALP gene expression in keratinocytes in psoriasis. 
Previous studies have shown that no elafin/SKALP is produced 
in normal epidermis [7]. Immunohistochemical staining also could 
detect the proteinase inhibitor neither in normal epidermis nor in 
non-lesional epidermis of psoriasis [15]. However, in situ hybridiza-
tion revealed that elafin/SKALP mRNA is synthesized in the gran-
ular layer of both normal and non-lesional epidermis. The localiza-
tion of elafin/SKALP gene expression corresponds with that of 
trans glutaminase 1 (keratinocyte trans glutaminase), a cross-linking 
enzyme to form the cornified envelope [16,19]. The substrates of 
the enzyme, such as involucrin, loricrin, and cystatin-lX, are also 
expressed in the granular layer [20 - 22]. In addition, elafin/SKALP 
is cross-linked by transglutaminases [11] . These findings suggest 
that elafin/SKALP is a constituent protein of the cornified enve-
lope. The reason for the discrepancy in the expression of the mRN A 
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and protein of elafin/SKALP remains unknown. The translation of 
elafin/SKALP may be highly suppressed by a post-transcriptional 
mechanism in normal and uninvolved psoriatic epidermis. 
In the development of psoriatic lesions, the gene expression of 
elafin/SKALP, which has been limited to the granular layer, be-
comes up-regulated, probably as a result of infiltration ofPMN into 
the epidermis. Keratinocytes may thus protect themselves and other 
skin components against the tissue damage caused by PMNs, result-
ing in the formation of a subcorneal microabscess. 
This work was slIpported itl part by a gratlt from the Mitlistry of Health atld Welfare 
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